Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online pharmacies say, in a sign the U.S. drugmaker is gaining ground on its ...

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some ...

A new study finds people who take weight-loss drugs also cut back on alcohol consumption. Researchers think the drugs could ...

Let's check out this ultimate pharma stock to buy now. Both drugs are based on the same molecule -- tirzepatide -- but Mounjaro is approved for type 2 diabetes, and Zepbound is approved for weight ...

I'm talking about Eli Lilly (NYSE: LLY), maker of Mounjaro and Zepbound. Both drugs are based on the same molecule — tirzepatide — but Mounjaro is approved for type 2 diabetes, and Zepbound is ...

Celebrities who have taken semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have experienced both health benefits and difficulties on the trendy drugs. GLP-1 drugs, once ...

Copyright 2024 The Associated Press. All Rights Reserved. FILE - Donna Cooper holds up a dosage of Wegovy, a drug used for weight loss, at her home, March 1, 2024, in ...

Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of Mounjaro and Zepbound, has also secured approval for its obesity treatments in the country, but has yet to launch them.

New images of the sun captured by the Solar Orbiter mission showcase the highest-resolution views of our star’s visible surface ever seen, revealing sunspots and continuously moving charged gas ...

Thanks to advances in technology, satisfying your curiosity by using an image to search to find more information is easy. Via a "reverse image search" on a computer or smartphone, you can find ...